RecruitingNot ApplicableNCT05789901

The MARVIN Chatbots to Provide Information for Different Health Conditions

A Master Research Protocol to Adapt and Evaluate an Artificial Intelligence Based Conversational Agent to Provide Information for Different Health Conditions: the MARVIN Chatbots

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Enrollment

400 participants

Start Date

Mar 1, 2024

Study Type

INTERVENTIONAL

Conditions

Breast Cancer HIV Infections Pediatric Emergency Medicine

Summary

This research is a continuation of a usability study with the MARVIN chatbot. The investigators aim to adapt the MARVIN chatbot to open it to other health domains (e.g. breast cancer) and populations (e.g. pharmacists). Therefore, this protocol constitutes a master research protocol that will englobe different research projects with individual chatbots. The investigators adopt an adaptive platform trial design, which will allow flexibility in handling multiple interventions adapted to different populations while retaining the characteristics of a platform trial design allowing early withdrawal of ineffective trial arms based on interim data (implementation outcomes) and introduction of new trial arms.

Eligibility

Min Age: 14 Years

Inclusion Criteria9

being 14 years or older;
being fluent in English and/or French;
being able to understand the requirements of study participation and provide informed consent during the duration of the study;
having access to a smartphone, tablet, or computer at home/at workplace;
having access to an internet connection at home or data plan on their device.
accept to use a Facebook Messenger-based Chatbot;
accept to use or create a personal Facebook account;
accept Facebook's privacy and data security policies.
any reason, in the opinion of the investigator, which would make the candidate inappropriate for participation in an investigative study involving a chatbot (e.g., cognitive deficit)